Research progress of immune checkpoint inhibitors in ovarian cancer

Research progress of immune checkpoint inhibitors in ovarian cancer

Ovarian cancer is the deadliest malignant tumor in the female reproductive system. Despite advancements in standard treatments such as tumor debulking surgery and platinum-based chemotherapy, the overall survival rate remains low. The emergence of targeted therapies, including Poly(ADP-ribose) polym...

Full description

Saved in:
Bibliographic Details
Main Authors: Lingli Zhao, Yanhong Zhai, Gaoli Niu
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2024-12-01
Series:Exploration of Immunology
Subjects:
ovarian cancer
immunotherapy
immune checkpoint inhibitors
combination therapy
Online Access:https://www.explorationpub.com/Journals/ei/Article/1003177
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items